#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile psoriatic arthritis Leukocyte adhesion deficiency Infantile apnoea Hyperinsulinaemic hypoglycaemia Acute graft versus host disease Progressive familial intrahepatic cholestasis Allogenic stem cell transplantation Arterial tortuosity syndrome Multiple system atrophy Vitamin B12 deficiency Hypereosinophilic syndrome Proteus syndrome ABO haemolytic disease of newborn Pulmonary arterial hypertension Congenital leptin deficiency More trials…

    Learn about Rare Diseases

    Alternating hemiplegia of childhood – Diagnostics Usher’s syndrome – Trials in Disease Soft tissue sarcoma – Trials in Disease Optic glioma – Life with Disease Synovial sarcoma recurrent – Treatment Marginal zone lymphoma – Life with Disease Angiosarcoma recurrent – Treatment Langerhans cell sarcoma – Basic Information Fabry’s disease – Trials in Disease Rhabdomyosarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Risperidone TIL CELLS Glimepiride Amlodipine Besilate Mk-0482 IMMUNOSTEM Mk-1167 AZD0022 Rp1 Gt005 Nelivaptan Pemigatinib Carbidopa Ambrosia Artemisiifolia (302) Spiramycin Alanyl Glutamine Dexamethasone Sodium Phosphate Exidavnemab Potassium Chloride Bidridistrogene Xeboparvovec More therapies…

    Learn about Your Condition

    Body mass index increased Pre-eclampsia Double hit lymphoma Pelvic venous thrombosis Eosinophilic oesophagitis Knee arthroplasty Labour induction Leiomyosarcoma recurrent Acute kidney injury Delayed graft function Leukaemia Sarcoma metastatic Labour pain Sarcoma Schizoaffective disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

HIV infection

  • Study on Switching to Doravirine and Islatravir for People with HIV-1 on Antiretroviral Therapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Cobicistat
    • Doravirine
    • Islatravir
    France Italy Spain

  • Study on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Doravirine
    • Islatravir
    • Bictegravir
    France Germany Italy The Netherlands Poland Spain

  • Study on Doravirine and Islatravir for People with HIV-1 Previously Treated with the Same Drug Combination

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Doravirine
    • Islatravir
    Finland France Germany Italy Poland Spain

  • Study on Switching HIV Treatment to Doravirine and Islatravir for Patients with HIV-1

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Doravirine
    • Islatravir
    • Bictegravir
    France Germany Italy Spain

  • Study of MK-8527 taken once monthly compared to emtricitabine/tenofovir taken daily for HIV-1 prevention

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Emtricitabine
    France

  • Study on Lenacapavir for HIV Prevention in Individuals at Risk of HIV Infection

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Tenofovir Disoproxil Fumarate
    • Emtricitabine
    • Lenacapavir
    France
Previous Page
1 … 3 4 5 6 7 … 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!